Table 6.
Logistic Regression Analysis Examining the Incidence of Individual Risk Factors From Baseline Examination to Follow‐Up Examination According to Biomarkers (Modeled Together)
| Δ MetS Component | No. | Incidence Proportion, % | RBP4 | Fetuin‐A | ||
|---|---|---|---|---|---|---|
| Multivariable Adjusteda OR (95% CI) | P Value | Multivariable Adjusteda OR (95% CI) | P Value | |||
| Waist circumference | 2208 | 916/2208 (41.5%) | 1.05 (0.93–1.18) | 0.42 | 1.04 (0.92–1.18) | 0.5 |
| Fasting glucose | 2207 | 369/2208 (16.7%) | 1.13 (0.99–1.28) | 0.06 | 1.03 (0.90–1.17) | 0.07 |
| Systolic BP | 2206 | 411/2206 (18.6%) | 1.22 (1.06–1.39) | 0.004 | 1.14 (1.00–1.30) | 0.04 |
| Diastolic BP | 2206 | 394/2206 (17.8%) | 1.19 (1.04–1.13) | 0.007 | 1.08 (0.95–1.22) | 0.26 |
| Triglycerides | 2206 | 441/2206 (20.0%) | 1.08 (0.96–1.23) | 0.19 | 0.99 (0.88–1.11) | 0.80 |
| HDL‐C | 2208 | 238/2206 (10.8%) | 1.05 (0.89–1.22) | 0.58 | 1.09 (0.94–1.26) | 0.26 |
BP indicates blood pressure; HDL‐C, high‐density lipoprotein cholesterol; RBP4, retinol‐binding protein 4.
a
Multivariable‐adjusted beta for change (Δ) in components of metabolic syndrome (MetS) are adjusted for age, sex, baseline body mass index (except waist circumference model), and baseline level of the individual component, and values are per SD increment of log biomarkers.